Xtx Topco LTD Apellis Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $1.3 Billion
- Q3 2024
A detailed history of Xtx Topco LTD transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 7,136 shares of APLS stock, worth $242,766. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,136Holding current value
$242,766% of portfolio
0.02%Shares
5 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$530 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$405 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$378 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$334 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$197 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.74B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...